Ciprian Catana, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Positron-Emission Tomography | 89 | 2024 | 6465 | 6.720 |
Why?
|
Magnetic Resonance Imaging | 79 | 2024 | 36290 | 2.570 |
Why?
|
Image Processing, Computer-Assisted | 30 | 2022 | 8950 | 2.060 |
Why?
|
Whole Body Imaging | 9 | 2022 | 278 | 1.850 |
Why?
|
Dopamine | 5 | 2022 | 1595 | 1.070 |
Why?
|
Fluorodeoxyglucose F18 | 18 | 2024 | 2007 | 1.060 |
Why?
|
Brain | 35 | 2024 | 26951 | 0.970 |
Why?
|
Movement | 4 | 2018 | 1474 | 0.960 |
Why?
|
Collagen Type I | 4 | 2024 | 616 | 0.910 |
Why?
|
Receptors, GABA | 10 | 2024 | 305 | 0.890 |
Why?
|
Abdomen | 4 | 2018 | 1130 | 0.830 |
Why?
|
Phantoms, Imaging | 14 | 2023 | 2512 | 0.740 |
Why?
|
Molecular Imaging | 5 | 2023 | 818 | 0.700 |
Why?
|
Radiopharmaceuticals | 16 | 2024 | 2634 | 0.680 |
Why?
|
Systems Integration | 3 | 2016 | 426 | 0.620 |
Why?
|
Respiratory-Gated Imaging Techniques | 1 | 2018 | 75 | 0.590 |
Why?
|
Tomography, X-Ray Computed | 14 | 2024 | 20509 | 0.580 |
Why?
|
Abdominal Neoplasms | 1 | 2018 | 286 | 0.550 |
Why?
|
Equipment Design | 6 | 2019 | 3520 | 0.540 |
Why?
|
Artifacts | 7 | 2020 | 1898 | 0.520 |
Why?
|
Gallium Radioisotopes | 5 | 2024 | 195 | 0.510 |
Why?
|
Receptors, Dopamine D1 | 1 | 2016 | 293 | 0.480 |
Why?
|
Algorithms | 18 | 2022 | 13981 | 0.470 |
Why?
|
Neuroglia | 5 | 2018 | 944 | 0.460 |
Why?
|
Nuclear Medicine | 3 | 2023 | 236 | 0.450 |
Why?
|
Respiration | 3 | 2018 | 1654 | 0.450 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2019 | 502 | 0.440 |
Why?
|
Fibrin | 6 | 2021 | 505 | 0.440 |
Why?
|
Receptors, Dopamine D2 | 5 | 2022 | 485 | 0.420 |
Why?
|
Metals | 1 | 2017 | 736 | 0.400 |
Why?
|
Acoustics | 1 | 2013 | 242 | 0.390 |
Why?
|
Head | 2 | 2019 | 922 | 0.380 |
Why?
|
Glioblastoma | 5 | 2019 | 3484 | 0.370 |
Why?
|
Raclopride | 5 | 2022 | 101 | 0.350 |
Why?
|
Prostheses and Implants | 1 | 2017 | 1273 | 0.340 |
Why?
|
Image Enhancement | 4 | 2017 | 2881 | 0.340 |
Why?
|
Memory, Short-Term | 1 | 2016 | 978 | 0.340 |
Why?
|
Motion | 4 | 2019 | 779 | 0.330 |
Why?
|
Contrast Media | 7 | 2019 | 5305 | 0.330 |
Why?
|
Humans | 89 | 2024 | 760621 | 0.290 |
Why?
|
Corpus Striatum | 3 | 2022 | 1233 | 0.290 |
Why?
|
Nerve Net | 2 | 2016 | 2261 | 0.280 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2006 | 141 | 0.270 |
Why?
|
Dementia | 2 | 2018 | 2649 | 0.270 |
Why?
|
Brain Mapping | 9 | 2018 | 6568 | 0.270 |
Why?
|
Receptors, Dopamine D3 | 3 | 2017 | 107 | 0.260 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 3 | 2019 | 1660 | 0.250 |
Why?
|
Transducers | 1 | 2006 | 240 | 0.250 |
Why?
|
Diffusion Magnetic Resonance Imaging | 5 | 2022 | 2782 | 0.250 |
Why?
|
Copper Radioisotopes | 2 | 2015 | 89 | 0.240 |
Why?
|
Neurology | 1 | 2012 | 779 | 0.240 |
Why?
|
Cerebral Cortex | 3 | 2024 | 5761 | 0.230 |
Why?
|
Subtraction Technique | 1 | 2006 | 510 | 0.220 |
Why?
|
Meninges | 1 | 2024 | 197 | 0.210 |
Why?
|
Acetamides | 3 | 2024 | 256 | 0.190 |
Why?
|
Amyotrophic Lateral Sclerosis | 3 | 2018 | 1463 | 0.190 |
Why?
|
BCG Vaccine | 1 | 2024 | 371 | 0.190 |
Why?
|
Male | 49 | 2024 | 359744 | 0.190 |
Why?
|
Reproducibility of Results | 11 | 2022 | 20080 | 0.190 |
Why?
|
Intracranial Thrombosis | 1 | 2021 | 109 | 0.180 |
Why?
|
Adult | 31 | 2024 | 219994 | 0.170 |
Why?
|
Monte Carlo Method | 2 | 2016 | 1257 | 0.170 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2017 | 1096 | 0.170 |
Why?
|
Echo-Planar Imaging | 2 | 2022 | 657 | 0.170 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 2 | 2024 | 254 | 0.160 |
Why?
|
Lung Injury | 1 | 2023 | 424 | 0.160 |
Why?
|
Yttrium Radioisotopes | 1 | 2019 | 107 | 0.160 |
Why?
|
Chicago | 1 | 2019 | 244 | 0.160 |
Why?
|
Nucleus Accumbens | 2 | 2022 | 365 | 0.160 |
Why?
|
Thrombosis | 4 | 2021 | 3052 | 0.160 |
Why?
|
Papio | 2 | 2017 | 661 | 0.150 |
Why?
|
Expert Testimony | 1 | 2021 | 361 | 0.150 |
Why?
|
Sensitivity and Specificity | 7 | 2021 | 14660 | 0.150 |
Why?
|
Thalamus | 2 | 2014 | 1041 | 0.150 |
Why?
|
Spleen | 1 | 2024 | 2298 | 0.150 |
Why?
|
Serotonin 5-HT1 Receptor Antagonists | 1 | 2017 | 8 | 0.150 |
Why?
|
Middle Aged | 29 | 2024 | 220352 | 0.150 |
Why?
|
Stilbenes | 1 | 2018 | 155 | 0.150 |
Why?
|
Drug Partial Agonism | 1 | 2017 | 24 | 0.150 |
Why?
|
Capillary Permeability | 2 | 2019 | 768 | 0.150 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2017 | 42 | 0.150 |
Why?
|
Atrial Appendage | 1 | 2021 | 292 | 0.150 |
Why?
|
Neuroendocrine Tumors | 1 | 2024 | 650 | 0.140 |
Why?
|
Normal Distribution | 1 | 2018 | 273 | 0.140 |
Why?
|
Skull | 3 | 2019 | 815 | 0.140 |
Why?
|
Female | 40 | 2024 | 391270 | 0.140 |
Why?
|
Motor Neuron Disease | 1 | 2017 | 98 | 0.140 |
Why?
|
Models, Biological | 1 | 2013 | 9467 | 0.140 |
Why?
|
Head Movements | 1 | 2018 | 152 | 0.140 |
Why?
|
Pelvis | 1 | 2021 | 743 | 0.140 |
Why?
|
Gadolinium | 2 | 2019 | 959 | 0.140 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2021 | 3765 | 0.130 |
Why?
|
Heart | 2 | 2020 | 4393 | 0.130 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 2 | 2024 | 556 | 0.130 |
Why?
|
Radiation Injuries | 1 | 2023 | 1183 | 0.130 |
Why?
|
Brain Neoplasms | 4 | 2019 | 8986 | 0.130 |
Why?
|
Quinpirole | 1 | 2015 | 32 | 0.130 |
Why?
|
Aged | 22 | 2024 | 169152 | 0.130 |
Why?
|
Venous Thrombosis | 2 | 2015 | 1299 | 0.130 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2019 | 270 | 0.130 |
Why?
|
Dopamine Agonists | 2 | 2015 | 352 | 0.130 |
Why?
|
Blood Glucose | 2 | 2024 | 6381 | 0.130 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2022 | 1046 | 0.130 |
Why?
|
Starvation | 1 | 2015 | 140 | 0.120 |
Why?
|
Hip | 1 | 2016 | 251 | 0.120 |
Why?
|
Radiometry | 2 | 2022 | 813 | 0.120 |
Why?
|
Photons | 2 | 2016 | 581 | 0.120 |
Why?
|
Animals | 26 | 2024 | 167963 | 0.120 |
Why?
|
Medical Oncology | 2 | 2019 | 2313 | 0.120 |
Why?
|
Workflow | 1 | 2019 | 852 | 0.120 |
Why?
|
Cholangiocarcinoma | 1 | 2019 | 550 | 0.110 |
Why?
|
Bile Duct Neoplasms | 1 | 2019 | 602 | 0.110 |
Why?
|
Object Attachment | 1 | 2017 | 324 | 0.110 |
Why?
|
Fibromyalgia | 1 | 2018 | 401 | 0.110 |
Why?
|
Low Back Pain | 1 | 2022 | 979 | 0.110 |
Why?
|
Placebo Effect | 1 | 2017 | 520 | 0.110 |
Why?
|
Aniline Compounds | 1 | 2018 | 1069 | 0.110 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2024 | 1724 | 0.110 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2017 | 3340 | 0.110 |
Why?
|
Analgesia | 1 | 2017 | 459 | 0.110 |
Why?
|
Mother-Child Relations | 1 | 2017 | 491 | 0.110 |
Why?
|
Signal Transduction | 1 | 2016 | 23376 | 0.110 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7475 | 0.110 |
Why?
|
Unconsciousness | 1 | 2014 | 251 | 0.100 |
Why?
|
Sensory Receptor Cells | 1 | 2017 | 509 | 0.100 |
Why?
|
Cardiovascular System | 1 | 2020 | 850 | 0.100 |
Why?
|
Bone and Bones | 2 | 2014 | 2560 | 0.100 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2018 | 801 | 0.100 |
Why?
|
Carbon Radioisotopes | 3 | 2018 | 557 | 0.100 |
Why?
|
Motor Neurons | 1 | 2016 | 865 | 0.100 |
Why?
|
Pyridines | 3 | 2024 | 2879 | 0.090 |
Why?
|
Thermogenesis | 1 | 2015 | 468 | 0.090 |
Why?
|
Models, Neurological | 3 | 2015 | 1758 | 0.090 |
Why?
|
Neoplasm Staging | 4 | 2019 | 11152 | 0.090 |
Why?
|
Plaque, Atherosclerotic | 1 | 2021 | 1518 | 0.090 |
Why?
|
Pyrimidines | 3 | 2018 | 3016 | 0.090 |
Why?
|
Basal Ganglia | 1 | 2013 | 552 | 0.090 |
Why?
|
Neurodegenerative Diseases | 1 | 2019 | 1084 | 0.090 |
Why?
|
Fibroblast Growth Factors | 1 | 2015 | 869 | 0.080 |
Why?
|
Cerebrovascular Circulation | 2 | 2017 | 2733 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2024 | 3455 | 0.080 |
Why?
|
Scattering, Radiation | 1 | 2011 | 488 | 0.080 |
Why?
|
Ventricular Function, Left | 1 | 2022 | 3880 | 0.080 |
Why?
|
Multiple Sclerosis | 1 | 2024 | 3204 | 0.080 |
Why?
|
Young Adult | 10 | 2024 | 58741 | 0.080 |
Why?
|
Motor Cortex | 1 | 2016 | 995 | 0.080 |
Why?
|
Dopamine Antagonists | 3 | 2015 | 288 | 0.080 |
Why?
|
Aged, 80 and over | 5 | 2018 | 58995 | 0.080 |
Why?
|
Adaptation, Physiological | 1 | 2015 | 1296 | 0.080 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2016 | 1375 | 0.080 |
Why?
|
Kinetics | 2 | 2013 | 6377 | 0.080 |
Why?
|
Hodgkin Disease | 1 | 2016 | 1378 | 0.080 |
Why?
|
Protons | 2 | 2018 | 1114 | 0.080 |
Why?
|
Delirium | 1 | 2020 | 1663 | 0.080 |
Why?
|
Organ Size | 1 | 2013 | 2254 | 0.080 |
Why?
|
Macaca mulatta | 4 | 2017 | 2316 | 0.080 |
Why?
|
Oxygen | 1 | 2020 | 4193 | 0.080 |
Why?
|
Pair Bond | 1 | 2007 | 9 | 0.080 |
Why?
|
Bayes Theorem | 1 | 2016 | 2326 | 0.080 |
Why?
|
tau Proteins | 1 | 2019 | 2085 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 2015 | 1266 | 0.080 |
Why?
|
Quinazolines | 2 | 2011 | 1363 | 0.070 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2011 | 666 | 0.070 |
Why?
|
Brain Concussion | 1 | 2019 | 1394 | 0.070 |
Why?
|
Time Factors | 5 | 2018 | 40165 | 0.070 |
Why?
|
Brain Injuries | 1 | 2019 | 2044 | 0.070 |
Why?
|
Pancreatic Neoplasms | 1 | 2024 | 5351 | 0.070 |
Why?
|
Prefrontal Cortex | 1 | 2017 | 2212 | 0.070 |
Why?
|
Pilot Projects | 2 | 2024 | 8555 | 0.070 |
Why?
|
Receptors, Opioid | 2 | 2017 | 145 | 0.060 |
Why?
|
Reference Values | 1 | 2013 | 4925 | 0.060 |
Why?
|
Visual Perception | 1 | 2014 | 1374 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2021 | 4319 | 0.060 |
Why?
|
Tissue Distribution | 2 | 2022 | 2262 | 0.060 |
Why?
|
Migraine Disorders | 1 | 2017 | 1693 | 0.060 |
Why?
|
Pandemics | 2 | 2022 | 8624 | 0.060 |
Why?
|
Phenotype | 2 | 2020 | 16546 | 0.060 |
Why?
|
Equipment Failure Analysis | 1 | 2006 | 848 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2019 | 22053 | 0.060 |
Why?
|
Neural Pathways | 1 | 2014 | 3040 | 0.060 |
Why?
|
Epilepsy | 1 | 2019 | 3267 | 0.060 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 3 | 2015 | 1067 | 0.060 |
Why?
|
Mice | 9 | 2024 | 81208 | 0.050 |
Why?
|
Pain | 2 | 2018 | 5066 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 9276 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 11712 | 0.050 |
Why?
|
Feasibility Studies | 4 | 2019 | 5201 | 0.050 |
Why?
|
Leucovorin | 1 | 2024 | 641 | 0.050 |
Why?
|
Radio Waves | 1 | 2023 | 250 | 0.050 |
Why?
|
Losartan | 1 | 2023 | 265 | 0.050 |
Why?
|
Radiotherapy Dosage | 2 | 2019 | 2897 | 0.050 |
Why?
|
Pulmonary Embolism | 1 | 2015 | 2543 | 0.050 |
Why?
|
Adolescent | 5 | 2024 | 87810 | 0.050 |
Why?
|
Rabbits | 2 | 2021 | 4773 | 0.050 |
Why?
|
Inflammation | 2 | 2020 | 10756 | 0.050 |
Why?
|
Breast Neoplasms | 3 | 2017 | 21025 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2014 | 3976 | 0.040 |
Why?
|
Fluorouracil | 1 | 2024 | 1631 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2024 | 6216 | 0.040 |
Why?
|
Radionuclide Imaging | 1 | 2023 | 1975 | 0.040 |
Why?
|
Lung | 2 | 2023 | 9994 | 0.040 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 2019 | 92 | 0.040 |
Why?
|
Technology, Radiologic | 1 | 2019 | 160 | 0.040 |
Why?
|
Afghanistan | 1 | 2019 | 79 | 0.040 |
Why?
|
Iraq | 1 | 2019 | 94 | 0.040 |
Why?
|
Aorta, Abdominal | 1 | 2021 | 625 | 0.040 |
Why?
|
Air | 1 | 2019 | 186 | 0.040 |
Why?
|
Computer Security | 1 | 2020 | 260 | 0.040 |
Why?
|
Computers | 1 | 2020 | 595 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2013 | 1544 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2013 | 4412 | 0.040 |
Why?
|
Receptor, Serotonin, 5-HT1B | 1 | 2017 | 36 | 0.040 |
Why?
|
Mice, Nude | 1 | 2024 | 3607 | 0.040 |
Why?
|
Prostatic Neoplasms | 2 | 2018 | 11345 | 0.040 |
Why?
|
Rats | 4 | 2015 | 23711 | 0.040 |
Why?
|
Carotid Arteries | 1 | 2021 | 951 | 0.040 |
Why?
|
Fibrosis | 1 | 2024 | 2042 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 6853 | 0.040 |
Why?
|
Neoplasms | 2 | 2019 | 22072 | 0.040 |
Why?
|
Biomedical Research | 1 | 2012 | 3426 | 0.040 |
Why?
|
Aging | 1 | 2016 | 8651 | 0.030 |
Why?
|
Organometallic Compounds | 2 | 2010 | 662 | 0.030 |
Why?
|
Mammals | 1 | 2022 | 1131 | 0.030 |
Why?
|
Neuroimmunomodulation | 1 | 2018 | 177 | 0.030 |
Why?
|
Carbon Isotopes | 1 | 2017 | 459 | 0.030 |
Why?
|
Prochlorperazine | 1 | 2015 | 16 | 0.030 |
Why?
|
Glioma | 1 | 2011 | 3420 | 0.030 |
Why?
|
Spin Labels | 1 | 2017 | 336 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2022 | 15289 | 0.030 |
Why?
|
Cell Line, Tumor | 3 | 2024 | 16939 | 0.030 |
Why?
|
Sodium Chloride | 1 | 2017 | 591 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2017 | 1385 | 0.030 |
Why?
|
Collagen | 1 | 2023 | 2636 | 0.030 |
Why?
|
Behavior, Animal | 2 | 2017 | 1866 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2022 | 844 | 0.030 |
Why?
|
Blast Injuries | 1 | 2019 | 322 | 0.030 |
Why?
|
Diprenorphine | 1 | 2014 | 13 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2017 | 631 | 0.030 |
Why?
|
Myocardium | 2 | 2022 | 4700 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2011 | 5643 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10827 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2015 | 8158 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2022 | 80372 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2024 | 2629 | 0.030 |
Why?
|
Pain Threshold | 1 | 2017 | 603 | 0.030 |
Why?
|
Computer Simulation | 2 | 2017 | 6218 | 0.030 |
Why?
|
Placebos | 1 | 2017 | 1668 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15757 | 0.030 |
Why?
|
Prognosis | 3 | 2019 | 29658 | 0.030 |
Why?
|
Oxytocin | 1 | 2017 | 401 | 0.030 |
Why?
|
Hypercapnia | 1 | 2014 | 261 | 0.030 |
Why?
|
Receptors, Progesterone | 1 | 2017 | 1130 | 0.020 |
Why?
|
Benzamides | 1 | 2017 | 1369 | 0.020 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2014 | 370 | 0.020 |
Why?
|
Arterial Occlusive Diseases | 1 | 2015 | 752 | 0.020 |
Why?
|
Random Allocation | 1 | 2015 | 2394 | 0.020 |
Why?
|
Cohort Studies | 3 | 2018 | 41335 | 0.020 |
Why?
|
Astrocytes | 1 | 2018 | 1338 | 0.020 |
Why?
|
Dexmedetomidine | 1 | 2014 | 316 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2015 | 1630 | 0.020 |
Why?
|
Fluorine | 1 | 2010 | 83 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 3113 | 0.020 |
Why?
|
Reward | 1 | 2017 | 963 | 0.020 |
Why?
|
Heterocyclic Compounds, 1-Ring | 1 | 2010 | 65 | 0.020 |
Why?
|
Adiponectin | 1 | 2015 | 1115 | 0.020 |
Why?
|
Heterocyclic Compounds | 1 | 2010 | 247 | 0.020 |
Why?
|
Microglia | 1 | 2018 | 1351 | 0.020 |
Why?
|
Narcotic Antagonists | 1 | 2014 | 583 | 0.020 |
Why?
|
Software | 2 | 2016 | 4419 | 0.020 |
Why?
|
Military Personnel | 1 | 2019 | 1244 | 0.020 |
Why?
|
Fasting | 1 | 2015 | 1603 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2017 | 1878 | 0.020 |
Why?
|
Diffusion | 1 | 2011 | 813 | 0.020 |
Why?
|
Extracellular Space | 1 | 2011 | 564 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2013 | 1850 | 0.020 |
Why?
|
Consciousness | 1 | 2014 | 602 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2017 | 2210 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2016 | 1489 | 0.020 |
Why?
|
Internet | 1 | 2020 | 3078 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2015 | 2362 | 0.020 |
Why?
|
Pitheciidae | 1 | 2007 | 2 | 0.020 |
Why?
|
Models, Chemical | 1 | 2010 | 614 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1215 | 0.020 |
Why?
|
Pain Measurement | 1 | 2017 | 3528 | 0.020 |
Why?
|
Indoles | 1 | 2015 | 1829 | 0.020 |
Why?
|
Glucose | 2 | 2010 | 4351 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2017 | 2554 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 25942 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2016 | 2385 | 0.020 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2008 | 415 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 7021 | 0.020 |
Why?
|
Molecular Structure | 1 | 2010 | 1895 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2010 | 2502 | 0.020 |
Why?
|
Veterans | 1 | 2019 | 2642 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2015 | 3215 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 2 | 2008 | 4048 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2015 | 18137 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2010 | 2192 | 0.010 |
Why?
|
Models, Statistical | 1 | 2018 | 5075 | 0.010 |
Why?
|
Child | 1 | 2010 | 79806 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11071 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2011 | 2049 | 0.010 |
Why?
|
Genotype | 1 | 2015 | 12960 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15840 | 0.010 |
Why?
|
Hydrocortisone | 1 | 2007 | 1803 | 0.010 |
Why?
|
Electroencephalography | 1 | 2014 | 6189 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2007 | 6238 | 0.010 |
Why?
|
Peptides | 1 | 2010 | 4354 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3527 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2024 | 65017 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2008 | 2526 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39261 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15789 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10446 | 0.010 |
Why?
|
Infant | 1 | 2017 | 36060 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2007 | 12159 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2008 | 22023 | 0.010 |
Why?
|
Prospective Studies | 1 | 2007 | 54303 | 0.000 |
Why?
|